Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. Targeting the gut–liver axis is a potential therapy for NASH. The Fufang Zhenzhu Tiaozhi (FTZ) capsule, a traditional Chinese medicine commonly used in clinical practice, has recently em...

Full description

Bibliographic Details
Main Authors: Tian Lan, Tonghao Xu, Yanfang Fu, Shuo Jiang, Xiaolin Liang, Ze Yu, Linyu Pan, Xianglu Rong, Jiao Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
NASH
gut–liver axis
intestinal barrier
intestinal microbiota
traditional Chinese medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.864703/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.864703/full

Similar Items